ON DEMAND: ESMO 2021 – ‘Game-Changers’ in GI, GU, breast cancer and survivorship

30 Sep 2021

Last night an expert panel presented game-changing data from the ESMO 2021 Congress in GI, GU and breast cancers, cancer survivorship and COVID-19, and discussed the impacts for Australian practice.

If you didn’t catch the webinar, you can watch on demand here:


Hosted by Professor Eva Segelov

Professor/Director of Oncology, Monash Health and Monash University. Board Member, Australasian Gastrointestinal Trials Group (AGITG), 2014-2020. Co-Founder, Commonwealth Neuroendocrine Tumour Collaboration (CommNETS).


GI cancer: Professor Chris Karapetis. Head of Medical Oncology, Flinders Medical Centre; Network Director of Cancer Services, Southern Area LHN, Adelaide; Director of Clinical Research in Medical Oncology, Flinders Medical Centre and Flinders Centre for Innovation in Cancer, Adelaide.

Breast cancer: Dr Sally Baron-Hay. Staff Specialist, Northern Sydney Cancer Centre, Royal North Shore Hospital; Medical Oncologist, GenesisCare North Shore; Conjoint Senior Lecturer, University of Sydney.

GU cancer: Associate Professor Ben Tran. Medical Oncologist, Peter MacCallum Cancer Centre, Melbourne.

Survivorship and COVID-19: Dr Kate Webber. Medical Oncologist, Monash Health and Adjunct Senior Lecturer, Monash University.


This event was created independently by the limbic in collaboration with the host and presenters. All studies were selected by the presenters, and all views expressed those of the host and presenters only. Thank you to our sponsors for providing the non-restrictive educational sponsorship that made this program possible. 

Already a member?

Login to keep reading.

Email me a login link